LeoVegas Q4: Record year with strong growth and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
LeoVegas Q4: Record year with strong growth and profitability

"With a record year characterised by strong organic growth, innovation and high profitability in the fourth quarter, LeoVegas has taken yet another solid step toward our financial targets " - Gustaf Hagman, Group CEO and co-founder

Fourth quarter: 1 October-31 December 2016 [1]

  • Revenue increased by 58% to EUR 41.2 m (26.0). Growth was entirely organic.
  • EBITDA amounted to EUR 10.0 m (0.4), corresponding to an EBITDA margin of 24.2% (1.5%).
  • Operating profit (EBIT) was EUR 9.5 m (0.2).
  • Earnings per share were EUR 0.10 (0.00) before and after dilution.
  • Cash and cash equivalents excluding customer balances amounted to EUR 56.2 m (19.4).
  • Mobile deposits accounted for 67% (59%) of total deposits, which grew 87% to EUR 139.1 m (74.2).
  • The number of depositing customers was 176,306 (100,852), an increase of 75%. The number of new depositing customers was 85,384 (46,690), an increase of 83%.
  • The number of returning depositing customers was 90,922 (54,162), an increase of 68%.

Full year 2016

  • Revenue increased by 70% to EUR 141.4 m (83.0). The growth of EUR 58.5 m was entirely organic.
  • EBITDA adjusted for items affecting comparability amounted to EUR 21.3 m (1.8), corresponding to an adjusted EBITDA margin of 15.1%. EBITDA amounted to EUR 16.0 m (1.2).
  • Operating profit adjusted for items affecting comparability was EUR 19.9 m (1.1), corresponding to an adjusted EBIT margin of 14.1%. Operating profit (EBIT) was EUR 14.6 m (0.5).
  • Earnings per share were EUR 0.14 before and after dilution.

Comment from Gustaf Hagman - Group CEO and co-founder

Fourth quarter Revenue grew 58% to EUR 41.2 m (26.0). Underlying growth is strong, with 87% growth in deposits during the quarter compared with the same period a year ago.

EBITDA improved considerably to EUR 10.0 m (0.4), corresponding to an EBITDA margin of 24.2%. The continued high profitability is explained by relatively lower but very effective marketing during the third and fourth quarters. Our marketing investments drive profitability, which will continue to be volatile from quarter to quarter.

During the final quarter of the year we launched in one more market - this time in Denmark, which is a regulated market. The launch has gone very well and has given us valuable experience ahead of future market launches.

Our two new gaming categories, LeoVegas Sport and LeoVegas Live Casino, have continued their strong development. New initiatives are being taken on a regular basis in these categories with new innovations designed to clearly differentiate LeoVegas' offering and continuously take the customer experience to new heights.

Full year 2016 During 2016 LeoVegas grew its revenue by more than EUR 58 m and thereby had what is likely the largest organic growth in the world of any listed gaming operator. At least within the online and mobile casino segment .

Revenue for the full year was EUR 141 m, and with an adjusted EBITDA margin of 15.1%, we can truly say that these figures have developed well towards our long-term targets of SEK 300 m in revenue and a 15% EBITDA margin in 2018.

Comments on first quarter 2017 Net gaming revenue (NGR) in January totalled EUR 14.1 m. Overall we are very pleased with how the KPIs in the first quarter have opened up, which gives us confidence for a strong development for the year on our path towards our 2018 financial targets.

LeoVegas has been named as Mobile and Online Casino Operator of the Year on repeated occasions - a title we now received again at both the EGR Nordic Awards and International Gaming Awards 2017

LeoVegas continues to develop according to our vision: to create the greatest gaming experience and be number one in mobile gaming.

With a strong cash position of over EUR 55 m, LeoVegas is poised to capitalise on the great opportunities in the industry.  

Presentation of the report - today at 09:00 CET To participate in the conference call, and thereby be able to ask questions, please call one of the following numbers: SE: +46 (0) 8 5033 6539, UK: +44 (0) 20 3427 1906, US: +1212 444 0895 code: 5325382 or join at the web  http://edge.media-server.com/m/p/8zhwxe7f

This information is information that LeoVegas AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on 15th of February 2017.

For further information, please contact:

Gustaf Hagman, Group CEO co-founder: +46 70-880 55 22, gustaf.hagman@leovegas.com Viktor Fritzén, Group CFO: +46 73-612 26 67, viktor.fritzen@leovegas.com Visitors address: Sveavägen 59, Stockholm Corporate identity number: 556830-4033

About the LeoVegas mobile gaming group LeoVegas' vision is to create the ultimate mobile gaming experience and be number one in mobile casino. The business is distinguished by award-winning innovation and strong growth. LeoVegas' technical development is conducted in Sweden, while operations are based in Malta. The Swedish parent company LeoVegas AB (publ) invests in companies that offer gaming via mobile devices and desktop computers along with companies that develop related technologies. LeoVegas has attracted major international acclaim and has won numerous awards, including "Nordic Operator of the year", "Mobile Marketing Campaign of the year", and "Innovation in Mobile and Tablet of the Year" at the international EGR Awards. LeoVegas bases its development on "Mobile First" and is at the forefront of using state-of-the-art technology in the mobile gaming market. With a foundation in a great gaming experience, long-term customer relationships and establishment of a strong brand, the company has attracted a steadily growing customer base through innovative, effective and data-driven marketing. Since its start, the mobile gaming company LeoVegas has shown strong quarter-on-quarter growth. LeoVegas' shares are listed on Nasdaq First North Premier. Avanza Bank AB is the company's Certified Adviser. For more about LeoVegas, visit www.leovegas.com and www.leovegasgroup.com .

[1] Throughout this report, figures in parentheses pertain to the same period a year earlier.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...50f4c4db29

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 277

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 250

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 88

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 241

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 47

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
IS: Thai Approval Opens New Sarcoma Treatment Path"> Continue Reading